SPHERA FUNDS MANAGEMENT LTD. 13D and 13G filings for Jasper Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-05 09:15 am Purchase | 2023-12-31 | 13G | Jasper Therapeutics, Inc. JSPR | SPHERA FUNDS MANAGEMENT LTD. | 7,130,625 6.390% | 6,561,912 (+1153.82%) | Filing |
| 2023-10-10 11:15 am Purchase | 2023-09-27 | 13G | Jasper Therapeutics, Inc. JSPR | SPHERA FUNDS MANAGEMENT LTD. | 568,713 5.130% | 568,713 (New Position) | Filing |